Actively Recruiting
Treatment of Sleep Apnea to Improve Metabolic Health - a Novel Approach to Unanswered Questions
Led by Uppsala University · Updated on 2025-02-27
600
Participants Needed
1
Research Sites
53 weeks
Total Duration
On this page
Sponsors
U
Uppsala University
Lead Sponsor
U
Uppsala University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to improve metabolic health by studying how treatment of obstructive sleep apnea (OSA) affects blood sugar control. It focuses on patients with OSA who also have diabetes or prediabetes, a common combination that can worsen health. The study seeks to answer key questions about how well continuous positive airway pressure (CPAP) therapy controls blood sugar, especially when sleep duration and long-term diabetes are considered. The project uses a large group of 600 patients followed for 18 months and collects detailed data on CPAP use, sleep patterns, other health conditions, lifestyle, and biomarkers related to metabolism. Participants diagnosed with OSA and planned for CPAP treatment will be followed over 12 months. The study does not involve experimental treatments but observes patients using CPAP as prescribed. Researchers will carefully track CPAP adherence and sleep duration, alongside various health measures. During the study, participants will undergo regular assessments of blood sugar control using measures like insulin resistance, glycated hemoglobin (HbA1c), blood glucose, insulin levels, and blood fats such as triglycerides and cholesterol. Data collection will continue from enrollment through the 12-month treatment period. The goal is to develop personalized treatment strategies for better glycemic control in patients using CPAP for OSA.
CONDITIONS
Brief Title
Treatment of Sleep Apnea to Improve Metabolic Health
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with obstructive sleep apnea
- Planned for CPAP treatment
- 18 years and above
You will not qualify if you...
- Patient not wanting to participate in study
- Non-Swedish speaking
- Judged by physician as non-fit for study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 months
Participants who plan to start CPAP treatment for sleep apnea are observed to assess metabolic health markers.
Visits from enrollment through 12 months
Trial Site Locations
Total: 1 location
1
Uppsala University
Uppsala, Uppsala County, Sweden
Actively Recruiting
Research Team
J
Jenny Theorell-Haglow, A.Prof, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here